NASDAQ · Biotechnology

OSRH (OSRH) Stock

$0.12 +0.00% NASDAQ: OSRH Healthcare

Valuation

MetricValue
Price$0.12
Market Cap$3.86M
P/E Ratio12.81
P/B Ratio0.13
P/S Ratio3.59
EPS (TTM)$-4.02
52-Week High$1.71
52-Week Low$0.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.74%
ROA-6.88%
ROCE-14.17%
Gross Margin-70.05%
Operating Margin-7.26%
Net Margin-5.25%
Debt/Equity0.05
Current Ratio0.18

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$4.0M$3.0M
Operating Profit$0$0$-2.0M$-12.0M$-18.0M
Net Profit$0$0$0$-10.0M$-18.0M
EPS$0.00$0.00$0.07$-0.54$-4.02
Op Margin———-331.2%-631.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$0$37.0M$2.0M$171.0M
Total Liabilities$1.0M$0$4.0M$9.0M$44.0M
Cash$0$0$0$0$2.0M
Borrowings$0$0$0$3.0M$4.0M

Latest News

OSR Health, A Message From the CEO ACCESS Newswire · Jul 13, 2026 CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target ACCESS Newswire · Jul 2, 2026 Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target ACCESS Newswire · Jul 2, 2026 OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares ACCESS Newswire · Jun 25, 2026 OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do ACCESS Newswire · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-1.0M$-2.0M$-4.0M
Investing Cash Flow$0$0$-34.0M$36.0M$-3.0M
Financing Cash Flow$0$0$-28.0M$-36.0M$0
Net Cash Flow$0$0$0$0$1.0M
Free Cash Flow$0$0$-1.0M$-2.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-4.19
FCF Yield-57.63%
Quick Ratio0.14
Interest Coverage-18.00
Return 1Y-60.34%
Return 3Y-95.91%
Return 5Y—

Ownership

Insiders Held48.97%
Institutions Held0.83%
Institutions Float Held1.63%
Institutional HolderSharesReport Date
Geode Capital Management, LLC105,7432026-03-31
Xtx Topco Ltd60,7462026-03-31
Vanguard Capital Management LLC37,3732026-03-31
Toronto Dominion Bank40,0002026-03-31
Vanguard Fiduciary Trust Co17,0292026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATIFATIF Holdings Ltd. $0.64 -12.79% -2.67 $7.63M 0.00%
BNIXBannix Acquisition Corp. $3.01 -66.56% -13.68 $7.65M 0.00%
BRLIBrilliant Acquisition Corporation $4.70 -45.85% -0.35 $8.53M 0.00%
CETUCetus Capital Acquisition Corp. $2.22 -62.18% — $8.53M 0.00%
EONREON Resources Inc. $0.47 -2.68% -1.04 $23.59M 0.00%

About OSRH

OSRH is led by CEO Kuk Hyoun Hwang, employs 19 people, headquartered in US, publicly traded since 2023.

OSRH stock trades at $0.12 with a market capitalization of $3.86M. The stock is valued at a price-to-earnings (P/E) ratio of 12.81, price-to-book of 0.13, price-to-sales of 3.59. Over the past 52 weeks the stock has ranged between $0.11 and $1.71, and currently trades 93.0% below its 52-week high.

On profitability, OSRH generates a return on equity (ROE) of -14.74%, return on capital employed of -14.17%, an operating margin of -7.26%, a net profit margin of -5.25%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides